YB

Yogesh Bhama

Active Director Director DIN 09765330
DIN 09765330 First appointment Oct 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Oct 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Yogesh Bhama

Data last updated:

Yogesh Bhama is a Director at Dayhz Biotech Private Limited (since 2025) and Director at Grip Medicament Private Limited (since 2022). The companies operate in Chemicals.

DIN 09765330
Primary Designation Director
Industry Chemicals
First Appointment 14 Oct 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dayhz Biotech Private Limited U46497RJ2025PTC107144
Director03 Oct 20252025Active
Grip Medicament Private Limited U24230RJ2022PTC084246
Director14 Oct 20222022Active

Board colleagues of Yogesh Bhama

Directorship timeline

Open interactive timeline →
Grip Medicament Private Limited
Dayhz Biotech Private Limited
Premium access

Shareholding and investment profile for Yogesh Bhama

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Bhama

Yogesh Bhama currently holds 2 directorships: Dayhz Biotech Private Limited (Director, since 03 Oct 2025); Grip Medicament Private Limited (Director, since 14 Oct 2022).

Yogesh Bhama was first appointed on 14 Oct 2022 as Director at Grip Medicament Private Limited. The most recent appointment on record is 03 Oct 2025 at Dayhz Biotech Private Limited.

The current boards of Yogesh Bhama's companies include Anil Kumar (Dayhz Biotech Private Limited), Deepak Khatri (Dayhz Biotech Private Limited), Harsh Soni (Dayhz Biotech Private Limited), Yunus Ali (Grip Medicament Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available